Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Escarrega, E. Alexandar"'
Autor:
Thiem, Vu Dinh, Anh, Dang Duc, Ha, Vu Hai, Van Thom, Nguyen, Thang, Tran Cong, Mateus, Jose, Carreño, Juan Manuel, Raghunandan, Rama, Huong, Nguyen Mai, Mercer, Laina D., Flores, Jorge, Escarrega, E. Alexandar, Raskin, Ariel, Thai, Duong Huu, Van Be, Le, Sette, Alessandro, Innis, Bruce L., Krammer, Florian, Weiskopf, Daniela
Publikováno v:
In Vaccine 12 January 2025 44
Autor:
Zhang, Zeli, Mateus, Jose, Coelho, Camila H., Dan, Jennifer M., Moderbacher, Carolyn Rydyznski, Gálvez, Rosa Isela, Cortes, Fernanda H., Grifoni, Alba, Tarke, Alison, Chang, James, Escarrega, E. Alexandar, Kim, Christina, Goodwin, Benjamin, Bloom, Nathaniel I., Frazier, April, Weiskopf, Daniela, Sette, Alessandro, Crotty, Shane
Publikováno v:
In Cell 7 July 2022 185(14):2434-2451
Autor:
Thiem VD; National Institute of Hygiene and Epidemiology, 1 Yersin Street, Hai Ba Trung District, Hanoi, Viet Nam., Anh DD; National Institute of Hygiene and Epidemiology, 1 Yersin Street, Hai Ba Trung District, Hanoi, Viet Nam., Ha VH; National Institute of Hygiene and Epidemiology, 1 Yersin Street, Hai Ba Trung District, Hanoi, Viet Nam., Van Thom N; Center for Disease Control, Thai Binh Province, 10 Hoàng Công Chất street, Quang Trung ward, Thai Binh, Viet Nam., Thang TC; PATH Vietnam, Hanoi Towers, 49 Hai Ba Trung Street, Hoan Kiem District, Hanoi, Viet Nam., Mateus J; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA., Carreño JM; Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP) at Mount Sinai New York, New York, NY, USA., Raghunandan R; Center for Vaccine Innovation and Access, PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA. Electronic address: rraghunandan@path.org., Huong NM; PATH Vietnam, Hanoi Towers, 49 Hai Ba Trung Street, Hoan Kiem District, Hanoi, Viet Nam., Mercer LD; Center for Vaccine Innovation and Access, PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Flores J; Center for Vaccine Innovation and Access, PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Escarrega EA; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA., Raskin A; Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP) at Mount Sinai New York, New York, NY, USA., Thai DH; Institute of Vaccines and Medical Biologicals, 9 Pasteur, Xuong Huan, Nha Trang City, Khanh Hoa, Viet Nam., Van Be L; Institute of Vaccines and Medical Biologicals, 9 Pasteur, Xuong Huan, Nha Trang City, Khanh Hoa, Viet Nam., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA; Department of Medicine, University of California, San Diego, (UCSD), La Jolla, CA, 92037, USA., Innis BL; Center for Vaccine Innovation and Access, PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP) at Mount Sinai New York, New York, NY, USA; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, NY, New York, USA. Electronic address: florian.krammer@mssm.edu., Weiskopf D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA; Department of Medicine, University of California, San Diego, (UCSD), La Jolla, CA, 92037, USA. Electronic address: daniela@lji.org.
Publikováno v:
Vaccine [Vaccine] 2024 Nov 29; Vol. 44, pp. 126542. Date of Electronic Publication: 2024 Nov 29.
Autor:
Gálvez RI; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA., Martínez-Pérez A; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA., Escarrega EA; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA., Singh T; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA., Zambrana JV; Sustainable Sciences Institute, Managua, Nicaragua.; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109-2029, USA., Balmaseda Á; Sustainable Sciences Institute, Managua, Nicaragua.; Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministerio de Salud, Managua, Nicaragua., Harris E; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA., Weiskopf D; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Division of Infectious Diseases and Global Public Health, School of Medicine, University of California, San Diego, La Jolla, CA 92037, USA.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 Feb 06. Date of Electronic Publication: 2024 Feb 06.
Autor:
Zhang Z, Mateus J, Coelho CH, Dan JM, Moderbacher CR, Gálvez RI, Cortes FH, Grifoni A, Tarke A, Chang J, Escarrega EA, Kim C, Goodwin B, Bloom NI, Frazier A, Weiskopf D, Sette A, Crotty S
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2022 Mar 21. Date of Electronic Publication: 2022 Mar 21.